Ensuring Adequate Nurse Staffing in a Public Health Emergency
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
Related Articles
Funding HAI and Antibiotic Resistance Research
AHRQ’s Healthcare-Associated Infections (HAI) Division funds clinical and health services research to develop the knowledge and practical tools used on the frontlines to prevent infections…
National Action Alliance for Patient and Workforce Safety Webinar
National Action Alliance for Patient and Workforce Safety Webinar announcement
Youth Drug Use Continues Historic Decline Post Pandemic
Adolescent substance use remains at record lows in 2024, extending declines first observed during the COVID-19 pandemic.
KRAKEN Trial Highlights Muvalaplin’s Efficacy, Safety in Reducing Lipoprotein(a)
Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).
Surveys on Patient Safety Culture for New Users
.yellow { background-color: #FDB81E; color: #323A45; } .yellow:hover { background-color: #FFF1D2; color: #323A45; }
AHRQ Research Funding Priorities & Special Emphasis Notices
AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause SymptomsAHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality,…
Ensuring Adequate Nurse Staffing in a Public Health Emergency
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
Empowering Pharmacists: Navigating Pediatric OTC Medications and Building Trust With Parents
Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with…
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable…
Ensuring Adequate Nurse Staffing in a Public Health Emergency
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania